MK-677 Research Lab Setup Guide

Setting up a research lab around MK-677 is mostly a sourcing and documentation problem, not an equipment problem. MK-677 (ibutamoren) is a non-peptide small molecule, so it behaves differently on the shelf and under analysis than the lyophilized peptides stored beside it — different identity testing, different handling expectations, different supplier questions. Before a first order goes out, a business buyer needs three things settled: purity documentation traceable to a specific lot, a storage and labeling system that keeps research material unambiguously separate from everything else in the building, and a written opinion from their own counsel on what the business is permitted to stock and resell.

This guide is written for the operator doing the buying — the med spa owner, clinic operator, telehealth founder, or reseller building a catalog. It covers the mechanics, the verification work, and where Real Peptides fits. All compounds discussed here are research use only. Nothing below is dosing, administration, or protocol guidance, and none of it is legal advice.

Why a small molecule changes your setup

Most research peptides arrive lyophilized in sealed vials with published storage conditions tied to the lot. MK-677 is not a peptide at all. The literature describes it as an orally bioavailable ghrelin receptor agonist studied as a growth hormone secretagogue, and research in that category is ongoing rather than settled. Practically, that means the analytical methods used to confirm identity and purity are not automatically the same ones a supplier runs on a peptide, and the storage condition published for a peptide lot does not transfer to it.

The operational consequence is simple: do not run a blanket storage or handling rule across a mixed catalog. Follow the condition published for each individual lot, and keep the documentation for each lot with the material rather than in a shared folder nobody opens. If your catalog mixes small molecules with peptide compounds such as Ipamorelin or CJC-1295 No DAC, your inventory system needs to treat them as separate handling classes from day one. Retrofitting that distinction after a few hundred units are already on the shelf is where traceability breaks.

Building the physical research space

The bench itself is the least expensive part of this. What matters to anyone who later reviews your operation is segregation, access control, and consistency.

Segregated storage. Research material lives in its own dedicated storage, physically separate from any consumer product, retail inventory, or anything intended for people. Shared refrigeration with unrelated stock is the most common and most avoidable setup error. Where a supplier publishes a refrigerated or frozen condition, use monitored storage and log the readings — a cheap continuous logger beats a thermometer somebody checks when they remember.

Labeling discipline. Every container carries the compound name, lot number, received date, and a research-use-only designation. Labels that drift into human-use language create a problem that no amount of back-end paperwork fixes. Keep the label vocabulary identical to the supplier's own.

Controlled access. Limit who can pull material and record who did. For a small operation that can be a locked cabinet and a bound logbook; for a larger one it is badge access and a scanned inventory system. The standard is the same either way: at any moment you can say which lot is where and who touched it last.

Written procedures. Short, specific SOPs for receiving, verifying against the certificate of analysis, storing, logging, and disposing of material. Three pages that staff actually follow outperform a thirty-page manual nobody reads. Review them when your catalog or your supplier changes.

Recordkeeping that holds up under scrutiny

Your records are the only durable evidence of how your operation runs. Build them to be readable by someone who was not there.

Start with a receiving log that captures supplier, compound, lot number, quantity, date received, and the condition of the shipment. Pair it with a COA archive where every lot number in your inventory maps to the specific certificate for that lot — not a generic document for the compound. That one-to-one mapping is the single most useful thing you can maintain, because it is the first thing anyone asks for and the hardest thing to reconstruct after the fact.

Add an outbound record if you are reselling, so each unit that leaves can be traced back to its lot. Keep research-use-only acknowledgments on file where your counsel advises you to collect them. Retain everything for whatever period your attorney recommends; retention requirements vary by business type and jurisdiction, so make that a question you ask rather than a number you guess.

The failure mode here is predictable. Businesses that treat COAs as a formality end up with a shelf full of material they cannot document, and material you cannot document has no verified provenance regardless of what it actually is.

What to verify before your first wholesale order

Supplier verification does more for your operation than any piece of lab equipment. Work through this before you commit to volume.

Two industry practices deserve specific caution. The first is selling the certificate of analysis as a paid add-on — documentation you have to buy is documentation most buyers will skip, which is precisely the point. The second is unverifiable testing language: a claim of third-party analysis that you cannot trace to a named lab, a named method, and a readable document is a marketing sentence, not a test result.

Questions for your attorney, not your supplier

This section is informational and is not legal advice. The licensing and regulatory picture for research compounds is genuinely complex, it differs by business type, and it is not something a supplier can resolve for you.

The productive approach is to bring your counsel a list of questions rather than an assumption. Useful ones include: what business licenses or registrations does an entity in my category need to purchase and hold research compounds? Does my state board impose any requirement on how research material is stored, labeled, or separated from other inventory? If I intend to resell, what does that change about my licensing posture, my labeling obligations, and my record retention? Are there restrictions specific to my professional license that apply regardless of how the material is designated? What documentation should I be collecting from downstream buyers?

What you should not do is accept a blanket statement — from any source, including a supplier's blog — that a particular activity is permitted or prohibited in your state. Those conclusions depend on facts about your specific business, and they change. Get the answer in writing from someone who is accountable for it, then build your setup around that answer.

How wholesale pricing and order minimums actually work

Wholesale programs in this category are generally structured around volume tiers: unit pricing improves as committed volume rises, with minimum order quantities setting the entry point for each tier. The variables that matter are how transparent those tiers are, whether minimums are per compound or per order, and how reorder cadence is handled once you have an account.

Minimums and margins vary widely by compound, category, and volume, and any supplier quoting you a universal number is describing their own program, not the market. The useful comparison is not headline price but landed cost against documentation quality. A lower per-unit price on material whose lot you cannot verify is not actually cheaper — it is an untested input with a discount attached.

Ask how pricing is published, whether tier changes require renegotiation, what the reorder process looks like, and how stockouts are communicated. Those operational details determine whether a wholesale relationship is workable at volume far more than the first quote does.

What Real Peptides does differently

Real Peptides operates a Wholesale Partner Program built around verification the buyer can perform independently. Compounds are tested to 99%+ HPLC purity. Every batch runs through a 7-panel test rather than a purity figure alone. Certificates of analysis are publicly verifiable — a prospective buyer can check lab results before opening an account, not after, and match a certificate to the lot received. Orders are fulfilled from the US in 5–7 days, which keeps reorder planning predictable and removes customs variability from your lead time.

Access runs through a 3-step wholesale application rather than a sales-call gauntlet. Pricing structure is published to partners rather than withheld as a negotiating lever. Catalog breadth spans the research categories most buyers build around, and compound availability is listed openly — if a specific compound such as MK-677 is on your sourcing list, check the current catalog rather than assuming category coverage.

None of these compounds are FDA-approved drugs, none are sold for human consumption, and the program is structured for buyers who understand that distinction and build their operations accordingly.

Where a qualified buyer goes from here

If your storage, labeling, and recordkeeping are in place and your counsel has signed off on what your business can hold and resell, the remaining step is supplier verification. Pull a certificate of analysis, check the method and the panel, confirm it matches a real lot, and compare that against whatever your current supplier provides. Buyers who clear that bar can submit the Wholesale Partner Program application at realpeptides.co and move to tier pricing from there.

For buyers mapping out catalog breadth, the Popular Peptides collection covers the highest-demand research compounds, while the Growth Factor and Tissue Signaling Research collection and the Performance and Recovery Research collection group compounds by research category — including items like Tesamorelin and BPC-157 that frequently appear alongside growth hormone secretagogue research in a stocked catalog.